181 related articles for article (PubMed ID: 21562162)
1. Prophylactic and therapeutic targeting of the neurokinin-1 receptor limits neuroinflammation in a murine model of pneumococcal meningitis.
Chauhan VS; Kluttz JM; Bost KL; Marriott I
J Immunol; 2011 Jun; 186(12):7255-63. PubMed ID: 21562162
[TBL] [Abstract][Full Text] [Related]
2. Human microglia and astrocytes constitutively express the neurokinin-1 receptor and functionally respond to substance P.
Burmeister AR; Johnson MB; Chauhan VS; Moerdyk-Schauwecker MJ; Young AD; Cooley ID; Martinez AN; Ramesh G; Philipp MT; Marriott I
J Neuroinflammation; 2017 Dec; 14(1):245. PubMed ID: 29237453
[TBL] [Abstract][Full Text] [Related]
3. Neurogenic exacerbation of microglial and astrocyte responses to Neisseria meningitidis and Borrelia burgdorferi.
Chauhan VS; Sterka DG; Gray DL; Bost KL; Marriott I
J Immunol; 2008 Jun; 180(12):8241-9. PubMed ID: 18523290
[TBL] [Abstract][Full Text] [Related]
4. Aprepitant limits in vivo neuroinflammatory responses in a rhesus model of Lyme neuroborreliosis.
Martinez AN; Burmeister AR; Ramesh G; Doyle-Meyers L; Marriott I; Philipp MT
J Neuroinflammation; 2017 Feb; 14(1):37. PubMed ID: 28202084
[TBL] [Abstract][Full Text] [Related]
5. The Therapeutic Potential of Targeting Substance P/NK-1R Interactions in Inflammatory CNS Disorders.
Johnson MB; Young AD; Marriott I
Front Cell Neurosci; 2016; 10():296. PubMed ID: 28101005
[TBL] [Abstract][Full Text] [Related]
6. Substance P Exacerbates the Inflammatory and Pro-osteoclastogenic Responses of Murine Osteoclasts and Osteoblasts to Staphylococcus aureus.
Johnson MB; Suptela SR; Sipprell SE; Marriott I
Inflammation; 2023 Feb; 46(1):256-269. PubMed ID: 36040535
[TBL] [Abstract][Full Text] [Related]
7. Chronic non-peptide neurokinin receptor antagonist treatment alters striatal tachykinin peptide and receptor gene expression in the rat.
McCarson KE; Krause JE; McLean S
Neurosci Lett; 1998 Jul; 251(2):113-6. PubMed ID: 9718987
[TBL] [Abstract][Full Text] [Related]
8. The role of tachykinins in central nervous system inflammatory responses.
Marriott I
Front Biosci; 2004 Sep; 9():2153-65. PubMed ID: 15353277
[TBL] [Abstract][Full Text] [Related]
9. NOD2 mediates inflammatory responses of primary murine glia to Streptococcus pneumoniae.
Liu X; Chauhan VS; Young AB; Marriott I
Glia; 2010 May; 58(7):839-47. PubMed ID: 20091781
[TBL] [Abstract][Full Text] [Related]
10. Targeting NK-1R attenuates renal fibrosis
Zhu E; Liu Y; Zhong M; Liu Y; Jiang X; Shu X; Li N; Guan H; Xia Y; Li J; Lan HY; Zheng Z
Front Immunol; 2023; 14():1142240. PubMed ID: 37033943
[TBL] [Abstract][Full Text] [Related]
11. Neurokinin-1 receptor antagonism improves postoperative neurocognitive disorder in mice.
Li Z; Luo T; Ning X; Xiong C; Wu A
Neurosci Lett; 2018 Nov; 687():189-195. PubMed ID: 30273701
[TBL] [Abstract][Full Text] [Related]
12. Suppression of autoimmune encephalomyelitis by a neurokinin-1 receptor antagonist--a putative role for substance P in CNS inflammation.
Nessler S; Stadelmann C; Bittner A; Schlegel K; Gronen F; Brueck W; Hemmer B; Sommer N
J Neuroimmunol; 2006 Oct; 179(1-2):1-8. PubMed ID: 16904192
[TBL] [Abstract][Full Text] [Related]
13. Substance P regulates Th1-type colitis in IL-10 knockout mice.
Weinstock JV; Blum A; Metwali A; Elliott D; Bunnett N; Arsenescu R
J Immunol; 2003 Oct; 171(7):3762-7. PubMed ID: 14500676
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous allergic contact dermatitis responses are diminished in mice deficient in neurokinin 1 receptors and augmented by neurokinin 2 receptor blockage.
Scholzen TE; Steinhoff M; Sindrilaru A; Schwarz A; Bunnett NW; Luger TA; Armstrong CA; Ansel JC
FASEB J; 2004 Jun; 18(9):1007-9. PubMed ID: 15084523
[TBL] [Abstract][Full Text] [Related]
15. The NK-1R Antagonist Aprepitant Prevents LPS-Induced Oxidative Stress and Inflammation in RAW264.7 Macrophages.
Zhao XN; Bai ZZ; Li CH; Sheng CL; Li HY
Drug Des Devel Ther; 2020; 14():1943-1952. PubMed ID: 32546961
[TBL] [Abstract][Full Text] [Related]
16. Neurokinin-1 receptor (NK-1R) expression is induced in human colonic epithelial cells by proinflammatory cytokines and mediates proliferation in response to substance P.
Goode T; O'Connor T; Hopkins A; Moriarty D; O'Sullivan GC; Collins JK; O'Donoghue D; Baird AW; O'Connell J; Shanahan F
J Cell Physiol; 2003 Oct; 197(1):30-41. PubMed ID: 12942538
[TBL] [Abstract][Full Text] [Related]
17. Advances in the research and application of neurokinin-1 receptor antagonists.
Hong X; Ma J; Zheng S; Zhao G; Fu C
J Zhejiang Univ Sci B; 2024 Feb; 25(2):91-105. PubMed ID: 38303494
[TBL] [Abstract][Full Text] [Related]
18. Expression of NK-1 receptor mRNA in murine T lymphocytes.
McCormack RJ; Hart RP; Ganea D
Neuroimmunomodulation; 1996; 3(1):35-46. PubMed ID: 8892359
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1beta upregulates functional expression of neurokinin-1 receptor (NK-1R) via NF-kappaB in astrocytes.
Guo CJ; Douglas SD; Gao Z; Wolf BA; Grinspan J; Lai JP; Riedel E; Ho WZ
Glia; 2004 Nov; 48(3):259-66. PubMed ID: 15390113
[TBL] [Abstract][Full Text] [Related]
20. Human neuronal cells (NT2-N) express functional substance P and neurokinin-1 receptor coupled to MIP-1 beta expression.
Li Y; Douglas SD; Pleasure DE; Lai J; Guo C; Bannerman P; Williams M; Ho W
J Neurosci Res; 2003 Feb; 71(4):559-66. PubMed ID: 12548712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
